What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His primary scientific interests are in Ovarian cancer, Cancer, Internal medicine, Odds ratio and Risk factor.
His Ovarian cancer research is multidisciplinary, incorporating perspectives in Cancer research, Gynecology, Serous fluid and Genome-wide association study.
Joellen M. Schildkraut interconnects Hysterectomy and Disease in the investigation of issues within Gynecology.
His work carried out in the field of Cancer brings together such families of science as Obstetrics, Epidemiology, Case-control study and Ovary.
Joellen M. Schildkraut has included themes like Differentially methylated regions, Endocrinology, Andrology and Oncology in his Internal medicine study.
His studies deal with areas such as Relative risk, Confidence interval, Randomized controlled trial, Family medicine and Prospective cohort study as well as Risk factor.
His most cited work include:
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality (965 citations)
- Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk (951 citations)
- The genetic attributable risk of breast and ovarian cancer (632 citations)
What are the main themes of his work throughout his whole career to date?
Joellen M. Schildkraut focuses on Internal medicine, Ovarian cancer, Oncology, Cancer and Odds ratio.
In his study, which falls under the umbrella issue of Internal medicine, Epigenetics, DNA methylation and Genomic imprinting is strongly linked to Endocrinology.
The study incorporates disciplines such as Serous fluid, Carcinoma, Gynecology and Single-nucleotide polymorphism, Genotype in addition to Ovarian cancer.
His biological study deals with issues like Proportional hazards model, which deal with fields such as Hazard ratio.
His research on Cancer often connects related areas such as Candidate gene.
The Odds ratio study combines topics in areas such as Logistic regression, Lower risk, Confidence interval, Epidemiology of cancer and Confounding.
He most often published in these fields:
- Internal medicine (56.39%)
- Ovarian cancer (56.39%)
- Oncology (45.70%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (56.39%)
- Oncology (45.70%)
- Ovarian cancer (56.39%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Oncology, Ovarian cancer, Odds ratio and Genome-wide association study.
Joellen M. Schildkraut combines subjects such as Body mass index, Case-control study, Glioma and Single-nucleotide polymorphism, Genotype with his study of Oncology.
His Ovarian cancer study combines topics in areas such as Epidemiology, Incidence, Breast cancer, Epidemiology of cancer and Hazard ratio.
His Odds ratio research also works with subjects such as
- Logistic regression which connect with Gynecology,
- Confidence interval that intertwine with fields like Population study,
- Obstetrics which is related to area like Pregnancy and Endometriosis,
- Family history which intersects with area such as Risk factor.
His Genome-wide association study study incorporates themes from Cancer research, Estrogen receptor, Genetic association and Germline.
He interconnects Relative risk and Quality of life in the investigation of issues within Cancer.
Between 2017 and 2021, his most popular works were:
- Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage. (90 citations)
- Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study (29 citations)
- Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21 (26 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
His primary areas of study are Internal medicine, Oncology, Genome-wide association study, Serous fluid and Cancer.
His Internal medicine research includes elements of Mendelian Randomization Analysis and Glioma.
His biological study spans a wide range of topics, including Mendelian randomization and Prostate.
His Genome-wide association study research incorporates elements of Methylation, DNA methylation, Genetic model, Case-control study and Genetic association.
His Serous fluid research includes themes of Ovarian carcinoma, Ovarian tumor, Ovarian cancer and Adenocarcinoma.
His specific area of interest is Cancer, where he studies Breast cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
